An interventional study of Succinylcholine and Rocuronium/Sugammadex in Intubating Conditions, Fasciculations and Postoperative Myalgia, sponsored by Dr. Horst Schmidt Klinik GmbH. Completed at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-07-18.
Sponsored by Dr. Horst Schmidt Klinik GmbH · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Patient Satisfaction with a site in Germany — 3 open to participants now, 3 under way, none of them phase 3. Patient Satisfaction · Germany.
Among the 22 studies in Patient Satisfaction with a site in Germany, this one is the 6th largest by enrollment of the 10 interventional ones that give a count, is the only one that started in 2011, is one of 7 with no phase, and was the 3rd registered.
880 studies on the registry are indexed under Patient Satisfaction; 204 are open to participants now.
Browse Patient Satisfaction studies →3 of the 22 studies in Patient Satisfaction with a site in Germany are open now. Recruiting first, the newest first:
LMU Klinikum · Sites in Germany
Ages 18–80
Augenklinik Ahaus G + H GmbH & Co. KG · Sites in Germany
Ages 22–85
Tobias Schreiber · Sites in Germany
Ages 18+
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 100 Patient Satisfaction studies recruiting now, 62 (62%) set no upper age limit and 30 (30%) stop at 75 or younger; 14 take children under 18; 26 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2011.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 105 is close to the median of 96 across 626 interventional studies indexed under Patient Satisfaction.
Median enrollment 123 across the 10 interventional studies, 116 across the 12 observational. Of the 16 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 22 have an industry lead sponsor. The 10 most frequent:
Dr. Horst Schmidt Klinik GmbH is the lead sponsor of 12 studies on the registry; none are open to participants now.
Dr. Horst Schmidt Klinik GmbH has 2 studies filed under Patient Satisfaction — fewer than ten, so there is no comparison to draw.
1 of the studies in Patient Satisfaction with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07424482Tobias SchreiberEducational Video to Improve Understanding and Reduce Anxiety in Heart Attack Patients | 2027-09-01 |
Add it to your calendar (.ics) → With an account.
Among the 22 studies in Patient Satisfaction with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Succinylcholine is commonly used for neuromuscular relaxation for short procedures such as rigid bronchoscopy. A more modern alternative is the application of low-dose rocuronium, reversed by low-dose sugammadex. The investigators compare the intubating conditions, incidence of postoperative myalgia (POM), as well as patient satisfaction for these two muscle relaxants.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patient received succinylcholine as a muscle relaxant(0.5 mg /kg)for induction of anaesthesia for rigid bronchoscopy.
Drug: Succinylcholine
Patient received rocuronium (0.25 mg/ kg) as muscle relaxant for induction of anaesthesia for rigid bronchoscopy, at the end of procedure rocuronium was reversed with sugammadex (0.5mg/kg.)
Drug: Rocuronium/Sugammadex
Patients received rocuronium (0.25 mg /kg)as muscle relaxant for induction of anaesthesia for rigid bronchoscopy.
Drug: Rocuronium
Anaesthesia was induced and maintained with propofol (1-2 mg/kg) and remifentanil (0.5 µg/kg). The study arm was immobilized and a dual electrode for peripheral nerve stimulation was placed over the ulnar nerve near the wrist. Neuromuscular monitoring was performed with accelerometry.The patients received succinycholine according to the study group.
Drug pages: Rocuronium · Sugammadex
Anaesthesia was induced and maintained with propofol (1-2 mg/kg) and remifentanil (0.5 µg/kg). The study arm was immobilized and a dual electrode for peripheral nerve stimulation was placed over the ulnar nerve near the wrist. Neuromuscular monitoring was performed with accelerometry.The patients received rocuronium/sugammadex according to the study group.
Anaesthesia was induced and maintained with propofol (1-2 mg/kg) and remifentanil (0.5 µg/kg). The study arm was immobilized and a dual electrode for peripheral nerve stimulation was placed over the ulnar nerve near the wrist. Neuromuscular monitoring was performed with accelerometry.The patients received rocuronium according to the study group.
Intubating condition
scoring system proposed for Good Clinical Research Practice using the following variables: conditions of inserting rigid bronchoscope, vocal cord position, and coughing
Time frame: After induction of general anaesthesia (after 3-5 minutes)
Fasciculations
Fasciculations were graded by the investigator on the following four-point scale 0 = no fasciculations 1. = mild, fine fasciculations of the eyes, neck, face or fingers, without limb movement 2. = moderate fasciculations occurring at more than two sites, or obvious limb movement 3. = vigorous or severe, sustained and widespread fasciculations in the trunk and limbs
Time frame: After application of the neuromuscular blocking agent (after 3-5 min)
Postoperative Myalgia (POM)
The severity of POM was measured using a four-point scale 0 = no myalgia 1. = minor pain limited to one area of the body 2. = muscle pain or stiffness noticed spontaneously by the patient, which may have required analgesic therapy 3. = generalized, severe, or incapacitating discomfort
Time frame: 72 Hours after Intervention
Sore throat
Measurement on an numeric ten point scale, the patients receive a questionaire
Time frame: 72 hours after intervention
Patient Satisfaction
Measurement on a numeric ten point scale the patients receive a questionaire
Time frame: 72 Hours after intervention
The record gives a start of Oct 2011, a primary completion of Mar 2012 and a completion of Mar 2012. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Succinylcholine · Rocuronium · Sugammadex
Dr. Horst Schmidt Klinik GmbH